Things that help with cancer
-
Milk fat reduces tumor growth in breast and colon tumours. Reduces side effects of chemo.
"The present study warrants the use of milk fat as an adjuvant to inhibit tumour metastasis during cancer chemotherapy, and to spare patients from the debilitating side-effects of cytotoxic drugs."
https://sci-hub.hlgczx.com/10.1007/s10585-011-9400-1#gsc.tab=0
-
Tumors partially destroyed with sound don't come back
https://www.sciencedaily.com/releases/2022/04/220418093955.htm?utm_source=dlvr.it&utm_medium=twitter
-
Low methionine + methioninase+ chemo for (pancreatic) cancer
1."Methionine restriction consisting of o-rMETase and a low-methionine diet, in combination with first-line chemotherapy, was highly effective in a patient with inoperable stage IV pancreatic cancer."
"After five months from the start of combination therapy, the size of the primary tumor decreased by 40% along with liver-metastasis regression."
https://pubmed.ncbi.nlm.nih.gov/39197890
/2."The patient began taking o-rMETase and went on a low-methionine diet one year after diagnosis which she has maintained without side effects for 7 months. The patient's CA19-9 level and tumor size remain stable 19 months after diagnosis."
https://pubmed.ncbi.nlm.nih.gov/354897273.Chemo + Methioninase obliterates tumor (purple line). Much More effective than chemo and methioninase alone.
https://pubmed.ncbi.nlm.nih.gov/296237584.Oral methioninase superior to injectable in mouse study .
https://pubmed.ncbi.nlm.nih.gov/29928962/5."All cancer cell types are methionine-addicted, which is termed the Hoffman effect. Cancer cells, unlike normal cells, cannot survive without large amount of methionine."
https://pubmed.ncbi.nlm.nih.gov/37168964/6."rMETase has arrested all cancer types tested in mouse models including patient-derived orthotopic xenograft (PDOX) models (23-49).
Oral administration of rMETase (o-rMETase) is highly effective on recalcitrant sarcoma, pancreatic cancer, colon cancer, and melanoma in PDOX models (24, 25, 26, 27, 31, 32, 33, 39, 40, 46)."
"A patient with high-stage ovarian cancer took o-rMETase twice a day at a dose of 250 units. After approximately one month of administration, the patient had no side effects. "
"The patient received o-rMETase for three months without any side effects and his PSA dropped approximately by 70% (Figure 2). The patient's overall performance was improved, with increased hemoglobin levels (Figure 3) and the patient was feeling much better during the time he was taking oral methioninase. "
"o-rMETase itself did not enter the bloodstream making it a far safer agent than injectable methioninase."
